VIJAYA · Health Care · 2026-08-21
Vijaya Diagnostic Centre Ltd
8.3★★★ PrimeStrong +13.2Stage 2 · wk 14In scan: Prop Scan · Pullback HunterMARKET: BULL RISING · 2026-08-21
₹1,504.4
+0.40% today
₹15,495 Cr · Mid cap
About this companyHealth Care· Hospitals & Diagnostic CentresExpand ▾
Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. The company offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T services. It also provides health checkups and home sample collection services. Vijaya Diagnostic Centre Limited was founded in 1981 and is based in Hyderabad, India.
Visit company website →P/E (TTM)
75.3
Forward 48.2
Earnings Growth (YoY)
+22.5%
Revenue +21.4%
Dividend Yield
0.17%
P/B 15.0
vs 52W High
-0.4%
₹861.4 lo₹1,510.6 hi
Near 52W high
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 14
1w13w26w
Week 14 — proven structure, sweet spot
How long this stock has been in Stage 2. The sweet spot is typically 13–26 weeks — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
33.3%
200 DMA: ₹1,128.7 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.35x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↑
MA20 trending up · +4.6% vs MA50 +4.1%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
Stage 2%
55.5%
20d Δ
+3.9pp
1M return
+2.7%
3M return
+9.6%
Sector Stage-2 % · last 20 days
This stock ranks #22 of 84 Stage 2 stocks in Health Care by RS.
Industry
Hospitals & Diagnostic Centres
Stage 2%
55.6%
20d Δ
-7.4pp
1M return
-2.8%
3M return
+2.0%
Industry Stage-2 % · last 20 days
Ranks #2 of 15 Stage 2 stocks in this industry. Top tier.
Price + Volume Chart
1M
+14.1%
3M
+22.6%
6M
+49.1%
YTD
+45.4%
1Y
+42.8%
Moving averages & range
50 DMA
₹1,373.3
200 DMA
₹1,128.7
52W High
₹1,510.6
52W Low
₹861.4
5D Low
₹1,490
Resistance levels (recent highs)
20d High
₹1,510.6
60d High
₹1,510.6
120d High
₹1,510.6
250d High
₹1,510.6
Next resistance
+0.4%
to 20d High
All analytics based on EOD data. Data as of 2026-08-21. Past data patterns are not indicative of future results. This page is a data analytics tool only.